Search research articles
Contact Us
Filters
Showing results (91-100 of 106) with videos related to
Page
of 11
Sort By:
Journal of the American College of Cardiology
|
June 29, 2026
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)
Mary Norine Walsh, Lars Kober, Karen Sliwa, et al.
European Heart Journal
|
June 29, 2026
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)
Mary Norine Walsh, Lars Kober, Karen Sliwa, et al.
Global Heart
|
July 6, 2026
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)
Mary Norine Walsh, Lars Kober, Karen Sliwa, et al.
European Heart Journal
|
January 12, 2023
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction
James P Curtain, Carly Adamson, Toru Kondo, et al.
Journal of the American College of Cardiology
|
February 2, 2013
Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity"
Thais Coutinho, Kashish Goel, Daniel Corrêa de Sá, et al.
European Journal of Heart Failure
|
December 18, 2024
Association between body mass index and clinical outcomes in patients with acute myocardial infarction and reduced systolic function: Analysis of PARADISE-MI trial data
Offer Amir, Gabby Elbaz-Greener, Shemy Carasso, et al.
Journal of Cardiac Failure
|
August 17, 2025
Growth differentiation factor-15 and the effect of dapagliflozin in heart failure: insights from the DAPA-HF trial
David D Berg, Kieran Docherty, Atefeh Talebi, et al.
European Journal of Heart Failure
|
February 20, 2021
Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial
João Pedro Ferreira, Brian L Claggett, Jiankang Liu, et al.
European Journal of Heart Failure
|
August 26, 2020
Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF
Senthil Selvaraj, Brian L Claggett, Marc A Pfeffer, et al.
Circulation
|
November 19, 2019
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
Scott D Solomon, Muthiah Vaduganathan, Brian L Claggett, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 106) with videos related to
Sort By:
Page
of 11
Journal of the American College of Cardiology
|
June 29, 2026
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)
Mary Norine Walsh, Lars Kober, Karen Sliwa, et al.
European Heart Journal
|
June 29, 2026
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)
Mary Norine Walsh, Lars Kober, Karen Sliwa, et al.
Global Heart
|
July 6, 2026
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)
Mary Norine Walsh, Lars Kober, Karen Sliwa, et al.
European Heart Journal
|
January 12, 2023
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction
James P Curtain, Carly Adamson, Toru Kondo, et al.
Journal of the American College of Cardiology
|
February 2, 2013
Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity"
Thais Coutinho, Kashish Goel, Daniel Corrêa de Sá, et al.
European Journal of Heart Failure
|
December 18, 2024
Association between body mass index and clinical outcomes in patients with acute myocardial infarction and reduced systolic function: Analysis of PARADISE-MI trial data
Offer Amir, Gabby Elbaz-Greener, Shemy Carasso, et al.
Journal of Cardiac Failure
|
August 17, 2025
Growth differentiation factor-15 and the effect of dapagliflozin in heart failure: insights from the DAPA-HF trial
David D Berg, Kieran Docherty, Atefeh Talebi, et al.
European Journal of Heart Failure
|
February 20, 2021
Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial
João Pedro Ferreira, Brian L Claggett, Jiankang Liu, et al.
European Journal of Heart Failure
|
August 26, 2020
Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF
Senthil Selvaraj, Brian L Claggett, Marc A Pfeffer, et al.
Circulation
|
November 19, 2019
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
Scott D Solomon, Muthiah Vaduganathan, Brian L Claggett, et al.
Page
of 11